Hemogenyx Pharmaceuticals has given the first-ever dose of its CAR-T cell therapy, HG-CT-1, to a human patient. The treatment targets relapsed or treatment-resistant acute myeloid leukaemia, offering hope for a tough-to-treat condition.
Seeing Machines has signed Mitsubishi Electric Mobility as a referral partner for its Guardian driver monitoring system. The deal is expected to boost sales of the AI-powered tech in the US commercial vehicle market.
Technology Minerals' battery recycling arm, Recyclus Group, has secured a licence to ship black mass to Europe under its deal with Glencore. The first 100-tonne shipment is set for March, marking a big step forward for the company.
Nostra Terra Oil and Gas is upbeat about its Pine Mills property, with production now averaging 130 barrels per day. The company has doubled output through well workover programmes, with more growth expected.
And Bluefield Solar Income Fund has generated £89 million through capital recycling after refinancing and selling part of its solar capacity. The move increased its fixed-rate debt to £297 million, with new debt maturing in 2035.
Follow us and subscribe on Youtube, our social channels and of course on proactiveinvestors.co.uk
